Lori Anne Kunkel, Director at Loxo Oncology, Inc. (LOXO), sold 5,900 shares at $132.81 ($782K) on 2018-04-20, disclosed to the SEC on 2018-04-24.
Open-market sale of $782k LOXO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $131.98 | 900 | $119K | 15.2% |
| 2 | $131.98 | 900 | $119K | 15.2% |
| 3 | $132.81 | 4,000 | $531K | 67.9% |
| 4 | $133.60 | 100 | $13K | 1.7% |
| Total | $132.57 avg | 5,900 | $782K | 100% |
| Filing → |
| CRIS | SELL | 2019-01-25 | $16K | — | Filing → |
| LOXO | SELL | 2018-10-03 | $852K | — | Filing → |
| LOXO | SELL | 2018-06-18 | $14.1M | — | Filing → |